Chemical and Pharmaceutical Bulletin p. 1510 - 1520 (1996)
Update date:2022-08-02
Topics:
Sakurai, Shunichiro
Ogawa, Nobuo
Suzuki, Tomio
Kato, Ken-Ichi
Ohashi, Tetsuo
Yasuda, Shingo
Kato, Hideo
As part of our search for a dual inhibitor possessing both thromboxane A2 (TXA2) receptor antagonistic and TXA2 synthase inhibitory activities, some [[(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives possessing a pyridyl or imidazolyl group were synthesized. Their TXA2 receptor antagonistic and TXA2 synthase inhibitory activities were evaluated in terms of the inhibitory effects on U-46619-induced guinea-pig platelet aggregation and on thromboxane B2 (TXB2) production in human platelets, respectively. It was found that 3-[4-[2-(1-imidazolyl)1-(4- chlorobenzenesulfonamido)ethyl]phenyl]propionic acid (22a), containing an imidazolyl group, is a well-balanced dual inhibitor having both TXA2 receptor antagonistic activity (IC50=0.31 μM) and TXA2 synthase inhibitory activity (IC50=0.39 μM).
View MoreXi'an Kaixiang Photoelectric Technology Co., Ltd
website:http://www.kxmaterials.com/
Contact:86-29-15991651477
Address:Building 6, Biopharmaceutical Industry R&D Cluster Base, No. 16, Caotang 4th Road, Caotang Science and Technology Industrial Base, High-tech Zone, Xi'an City, Shaanxi Province, China
Xinchang Jiu Xin Pharmaceutical Co., Ltd
website:http://www.jiuxinpharm.com
Contact:86 137 5756 8585
Address:Poyang industry Park
Contact:+86-633-8332928
Address:No.1,Huanghai Yilu.Rizhao,Shandong
Anhui Redstar Pharmaceutical Corp., Ltd
Contact:+86-563-5120837
Address:Jingxian Industrial Development Zone, Anhui , China
Contact:+86-10-62651721
Address:29 Yongxing Road, Daxing District,Beijing China
Doi:10.1016/j.tetlet.2007.08.108
(2007)Doi:10.1016/0040-4039(96)01504-3
(1996)Doi:10.1016/j.tetlet.2014.10.043
(2014)Doi:10.1016/S0040-4039(00)74478-9
(1991)Doi:10.1016/0040-4020(96)00652-7
(1996)Doi:10.1016/0040-4020(96)00613-8
(1996)
